METTL3 promotes adriamycin resistance in MCF-7 breast cancer cells by accelerating pri-microRNA-221-3p maturation in a m6A-dependent manner

Co-expression of HIF-1α, MDR1 and LAPTM4B in peripheral blood of solid tumors

(2019) Zaira Rehman et al.   PeerJ

METTL3 promote tumor proliferation of bladder cancer by accelerating pri-miR221/222 maturation in m6A-dependent manner

(2019) Jie Han et al.   Molecular Cancer

miR-221 Targets QKI to Enhance the Tumorigenic Capacity of Human Colorectal Cancer Stem Cells

(2019) Junko Mukohyama et al.   CANCER RESEARCH

N6-methyladenosine METTL3 promotes the breast cancer progression via targeting Bcl-2

(2019) Hong Wang et al.   GENE

N6-methyladenosine modification of ITGA6 mRNA promotes the development and progression of bladder cancer

(2019) Huan Jin et al.   EBioMedicine

m6A mRNA methylation initiated by METTL3 directly promotes YAP translation and increases YAP activity by regulating the MALAT1-miR-1914-3p-YAP axis to induce NSCLC drug resistance and metastasis

(2019) Dan Jin et al.   Journal of Hematology & Oncology

Autophagy and doxorubicin resistance in cancer

(2018) Chao Chen et al.   ANTI-CANCER DRUGS

microRNA-129-5p suppresses Adriamycin resistance in breast cancer by targeting SOX2

(2018) Huijuan Zeng et al.   ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS

Natural product toosendanin reverses the resistance of human breast cancer cells to adriamycin as a novel PI3K inhibitor

(2018) Wang Kai et al.   BIOCHEMICAL PHARMACOLOGY

Analysis of miRNA-221 Expression Level in Tumors and Marginal Biopsies from Patients with Breast Cancer (Cross-Sectional Observational Study)

(2018) Atefe Abak et al.   Clinical Laboratory

N 6 -methyladenosine mediates the cellular proliferation and apoptosis via microRNAs in arsenite-transformed cells

(2018) Shiyan Gu et al.   TOXICOLOGY LETTERS

4-Hydroxybenzoic acid (4-HBA) enhances the sensitivity of human breast cancer cells to adriamycin as a specific HDAC6 inhibitor by promoting HIPK2/p53 pathway

(2018) Xu-Na Wang et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

(2018) Freddie Bray et al.   CA-A CANCER JOURNAL FOR CLINICIANS

miR-221/222 promote tumor growth and suppress apoptosis by targeting lncRNA GAS5 in breast cancer

(2018) Yuanyuan Zong et al.   BIOSCIENCE REPORTS

miR-381 overcomes cisplatin resistance in breast cancer by targeting MDR1

(2018) Dandan Yi et al.   CELL BIOLOGY INTERNATIONAL

MiR-222 promotes drug-resistance of breast cancer cells to adriamycin via modulation of PTEN/Akt/FOXO1 pathway

(2017) Hongyu Shen et al.   GENE

miR-221 and miR-222 synergistically regulate hepatocyte growth factor activator inhibitor type 1 to promote cell proliferation and migration in gastric cancer

(2017) Tao Ning et al.   TUMOR BIOLOGY

The role of oncomirs in the pathogenesis and treatment of breast cancer

(2016) Maryam Hemmatzadeh et al.   BIOMEDICINE & PHARMACOTHERAPY

Classification, Treatment Strategy, and Associated Drug Resistance in Breast Cancer

(2016) Yuan Tang et al.   Clinical Breast Cancer

miR-302a/b/c/d cooperatively inhibit BCRP expression to increase drug sensitivity in breast cancer cells

(2016) Yan Wang et al.   GYNECOLOGIC ONCOLOGY

Prognostic and biological significance of microRNA-221 in breast cancer

(2015) Sanaa Eissa et al.   GENE

The investigation of miR-221-3p and PAK1 gene expressions in breast cancer cell lines

(2015) Sercan Ergun et al.   GENE

Discovering Che-1/AATF: a new attractive target for cancer therapy

(2015) Simona Iezzi et al.   Frontiers in Genetics

miR-221/222 Promotes S-Phase Entry and Cellular Migration in Control of Basal-Like Breast Cancer

(2014) Yuan Li et al.   MOLECULES

HIPK2 sustains apoptotic response by phosphorylating Che-1/AATF and promoting its degradation

(2014) F De Nicola et al.   Cell Death & Disease

Apoptosis-antagonizing transcription factor (AATF) gene silencing: role in induction of apoptosis and down-regulation of estrogen receptor in breast cancer cells

(2013) Monika Sharma   BIOTECHNOLOGY LETTERS

Doxorubicin-Loaded Nanoparticles: New Advances in Breast Cancer Therapy

(2012) Jose Prados et al.   Anti-Cancer Agents in Medicinal Chemistry

HIPK2 downregulates vimentin and inhibits breast cancer cell invasion

(2012) Cristina Nodale et al.   CANCER BIOLOGY & THERAPY

Plasma miR-221 as a Predictive Biomarker for Chemoresistance in Breast Cancer Patients who Previously Received Neoadjuvant Chemotherapy

(2011) Ruihua Zhao et al.   ONKOLOGIE

The significance of expression of autophagy-related gene Beclin, Bcl-2, and Bax in breast cancer tissues

(2011) Qing Yao et al.   TUMOR BIOLOGY